Intensive coursework, followed by group discussions and networking. Enrollment is limited. Upon successful completion of all classes of the program, students receive a Statement of Completion and they may be recommended for CERSI internships, scholarships, and fellowships.
Download the pdf version of the flyer
Spring 2018 Agenda
April 2 - April 20, 2018
|April 2||9AM -- 2PM||Online||Introduction to US FDA|
|April 4||9AM -- 2PM||Stanford University||Medical Device Development and Regulation|
|April 6||9AM -- 2PM||Stanford University||New Drug Development and Regulation|
|April 9||9AM -- 2PM||Stanford University||Large Molecule Development and Regulation|
|April 11||9AM -- 2PM||Stanford University||Non-clinical Safety Assessment|
|April 13||9AM -- 2PM||Stanford University||Early Clinical Drug Development|
|April 16||9AM -- 2PM||Stanford University||510(k) Regulatory Pathways for Medical Devices|
|April 18||9AM -- 2PM||Stanford University||Biomarkers in Drug Development and Approval|
|April 20||9AM -- 2PM||Stanford University||Post Marketing Considerations for Drugs|
April 17, 12pm-1pm - Challenges in the regulation of high cost treatments - An overview from Latin America.